|
HELB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.155880E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.718100E-03 |
| Normal-vs-Stage2 |
5.675800E-01 |
| Normal-vs-Stage3 |
4.845400E-01 |
| Normal-vs-Stage4 |
4.336200E-01 |
| Stage1-vs-Stage2 |
1.485970E-01 |
| Stage1-vs-Stage3 |
6.348200E-02 |
| Stage1-vs-Stage4 |
4.421200E-01 |
| Stage2-vs-Stage3 |
9.754800E-01 |
| Stage2-vs-Stage4 |
7.853000E-01 |
| Stage3-vs-Stage4 |
7.719800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.045640E-02 |
| Normal-vs-AfricanAmerican |
6.325600E-02 |
| Normal-vs-Asian |
6.051000E-01 |
| Caucasian-vs-AfricanAmerican |
6.318800E-01 |
| Caucasian-vs-Asian |
5.579800E-01 |
| AfricanAmerican-vs-Asian |
6.874600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.039900E-03 |
| Normal-vs-Female |
8.203200E-01 |
| Male-vs-Female |
2.425500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.998820E-01 |
| Normal-vs-Extreme_Weight |
8.774100E-04 |
| Normal-vs-Obese |
2.501400E-01 |
| Normal-vs-Extreme_Obese |
2.060800E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.604490E-02 |
| Normal_Weight-vs-Obese |
7.988800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.312300E-02 |
| Extreme_Weight-vs-Obese |
1.724820E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.787000E-01 |
| Obese-vs-Extreme_Obese |
1.028280E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.702800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.092300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.959330E-03 |
| Normal-vs-Age(81-100Yrs) |
1.072490E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.562430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.697930E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.603700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.206400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.724410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.742200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.077500E-03 |
| Normal-VS-Type2 PRCC |
5.410200E-02 |
| Normal-VS-KIRP CIMP |
2.425200E-01 |
| Normal-VS-Unclassified PRCC |
4.996000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.221220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.356100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.466100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.658600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.581400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.013030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.756800E-03 |
| Normal-vs-N1 |
4.434400E-01 |
| Normal-vs-N2 |
7.978200E-01 |
| N0-vs-N1 |
1.204030E-02 |
| N0-vs-N2 |
3.008800E-01 |
| N1-vs-N2 |
5.972200E-01 |
|
|
